Prognostic markers in AML include mutations in the NPM1, FLT3, MLL, and CEBPα genes, as well as alterations in the expression levels of BAALC, MN1, ERG, and AF1q,10 and chromosomal abnormalities such as t(8;21) and t(15;17).11 Here, FLT3 is linked to acute myeloid leukemia.